When sadness becomes more than a passing mood

February 16, 2021

TALK – someone wants to hear you

As another school year gets underway in an increasingly competitive world, spare a thought for teens who find themselves isolated, lonely, vulnerable and unable to share their deepest fears in the time of COVID-19. 

Psychiatrist Dr Ulli Meys, who specialises in adolescent mental health at Akeso Kenilworth in Cape Town, says that in the last decade suicide has risen sharply among 15 to 18 year olds. “Every day we see patients who may feel suicidal, who have suicidal intent or who have attempted suicide.”

“Teenage suicide is highly complex. It is devastating and has profound consequences, leaving scars for generations. Tragically, there are few people available to treat adolescents who present with mental health issues. Few facilities offer specialised adolescent units and the outlook is fairly bleak as they are becoming fewer still. Furthermore, they are often not well resourced or easily accessible. Due to the specialised nature of adolescent care, a particular licence is required to treat minors – those under 18. In addition, not enough people are being trained,” he notes.

Risk factors 
“There are multiple risk factors when it comes to teenage suicide,” comments Dr Meys. “The highest risk factor in adolescents is mental illness. Additional risk factors include a history of substance abuse and self-harming behaviour. 

“Any individual who engages in self-harm is at higher risk of suicide. A large number of patients attempting suicide have self-harm scars on their bodies. Self-harm is often seen as a coping mechanism. The adolescent is overwhelmed by feelings and emotions and has to substitute emotional pain with physical pain as it is easier to bear. Another reason for self-harm could be self-punishment. 

“Bullying, and nowadays, increasingly, cyber bullying, is another risk factor that can trigger distress and suicidal behaviour. It is therefore important to ascertain if the individual has been or is being overtly or covertly bullied.  

“Family conflict, lack of support and a history of abuse and sexual abuse are also risk factors. In addition, a family history of suicide can be a factor. 

“Suicidal ideation is not a stand-alone condition. It grows out of depression, which often drives suicidal thoughts,” says Mark de la Rey, a clinical psychologist practising at Akeso Kenilworth Adolescents/Young Adults (KAYA) mental health facility in Claremont, Cape Town. 

“What makes suicide so complex is impulsivity. We live in a world of instant gratification where irreversible lethal attempts are sometimes made in an attempt to relieve pain or immediately escape a distressing situation. Adolescents are impulsive, even in play. They are also easily overwhelmed, making the matter more dangerous,” adds De la Rey.

Dr Meys says that teenage girls are four times more likely to attempt suicide than boys. “Boys, on the other hand, are four times more successful. Girls are more likely to overdose, which provides a window of opportunity and this means you can still treat them as it is not always lethal. This however does not mean that vigilance is not all important.

“Boys tend to remain quiet and it is quite rare for boys and men to talk about their feelings. Unfortunately boys tend to use more violent and more lethal means of killing themselves. In addition males are less prone to speak about their emotional difficulties making it more difficult to recognise their distress. 

Prevention and treatment
According to De la Rey, numerous studies have shown that early intervention is key. In instances where teenagers attempt suicide screening it is important to establish any underlying mental illness and what stressors and risk factors are present.  

“While teenagers want to demonstrate their independence it is important for parents to keep the door open at all times – they should be accessible and make themselves available. If parents notice a change in behaviour it is important to engage and see a general practitioner as a first step.   

“Get the adolescent screened so that a diagnosis can be made. This will result in immediate relief as the child feels heard. If one looks at anti-depressants and treating mental illness it needs to be a broad, balanced approach including therapy and medication. It takes two to four weeks for anti-depressants to work and even if the patient feels better after two months, the medication should be continued for at least six months. If medication is stopped too soon there will be a relapse. More importantly, regular follow-ups are mandatory,” explains Dr Meys.

He says the assessment of suicidality in individuals is highly complex. “Many adolescents may have fleeting suicidal thoughts while some are having what we call suicidal intentions. It is therefore imperative to determine where the individual falls on the scale. 

“Anyone who attempts suicide, serious or not, requires an assessment and intervention. If they have to go to that length to be heard, they have problems that need to be addressed. They are clearly not talking about their problems. Most teenagers who attempt suicide have tried before and they must be acknowledged and helped. It is important to build in a safety net for them and it is vital that we recognise and treat the underlying problems.

“If we want to address teen suicide we need to identify mental illness. Often general practitioners, paediatricians and school counsellors may be the first port of call. While seeking further professional help is challenging in these difficult financial times, it is of great importance,” notes Dr Meys.

Teen suicide and the pressures of COVID-19
For many adolescents the pressures of COVID-19 came at a time when teen suicides were already at an all-time high. While South African statistics are often lagging, data released late last year by the Center for Disease Control and Prevention in the United States of America indicated suicide is the second leading cause of death among people aged 10-24, after accidents.

In referring to an article by Takanao Tanaka & Shohei Okamoto published in the January 2021 edition of Nature Human Behaviour, Dr Meys notes that teen suicide can be anything from the second, fourth and fifth most significant cause of death, depending on where in the world you are, and whether your country of residence is in the developed or undeveloped world. In Japan, according to the article, there has been an increase in suicide following an initial decline during the COVID-19 pandemic.

The Nature article, which uses a difference-in-difference estimation, indicates that monthly suicide rates declined by 14% during the first five months, from February to June 2020, of the pandemic. This is attributed to a number of complex reasons, including the government of Japan’s generous subsidies, reduced working hours and school closure. However, by contrast, “monthly suicide rates increased by 16% during the second wave (July to October 2020), with a larger increase among females (37%) and children and adolescents (49%).”
 
De la Rey believes that social distancing and isolation could make matters worse for young people. “In the teenage years friends are often closer than family; that is not unusual and is a totally natural part of the developmental cycle. The social distancing required during COVID-19 does not help when you cannot see your friends, participate in sport or engage with your teachers. As it is, many teenagers already feel isolated and being cooped up at home does not help.” 

"At this stage everyone feels a little isolated, and it has been very tough for everybody – even for those who have never experienced any sign of depression. Some of our young patients, in fact, had no clue as to why they were depressed.

“But, just put yourself in the shoes of teens in 2020 or 2021. There has been a twelve-year build-up to the final school year for matric students, for example. Everyone has fought hard to get to that end goal, and now many of these special milestones are being taken away. From finally joining the first rugby or netball team to the matric dance, that final camp, the last day of school – now suddenly you cannot experience any of those things you have worked towards,” says De la Rey.

“All suicide threats or indications should be taken seriously and acted upon to keep safe. There is no shame in seeking assistance and it is certainly better to be safe than sorry in such cases. Reaching out for professional help to support a young person who may be in danger of harming themselves can avert tragedy and save lives. Talk, someone wants to hear you,” encourages De la Rey.

For information about occupational or mental health services, accessing care, information about mental health issues, or if you are in an emotional crisis, Akeso is here to help. Contact info@akeso.co.za or visit www.akeso.co.za. In the event of a psychological crisis, emergency support can be reached on 0861 435 787, 24 hours a day.

Out-patient psychologist and occupational therapist consultations can be booked via www.copetherapy.co.za and psychiatrist consultations through Netcare appointmed™, online at www.netcareappointmed.co.za or by calling 0861 555 565. The COPE Therapy website www.copetherapy.co.za also contains many useful blog posts on various issues and tips relating to mental health.
Neurologist Dr. Michael Huth emphasises the importance of understanding different migraine types
May 3, 2025
Migraines affect 15% of the global population, causing severe pain and disrupting daily life. Neurologist Dr. Michael Huth emphasises the importance of understanding different migraine types and their triggers.
Dr Michael de Villiers explains why people can become sick every flu season
April 21, 2025
Dr Michael de Villiers explains why people can become sick every flu season and why the influenza vaccine is generally recommended every year.
Dr Mpho Ramabulana stresses the importance of early detection of colorectal cancer.
April 11, 2025
Colorectal cancer, one of the most prevalent yet preventable cancers, can develop in the colon or rectum, often starting as small polyps that can quietly become malignant if left unchecked. Dr Mpho Ramabulana, a colorectal surgeon and gastroenterologist at Netcare Akasia Hospital, underscores the life-saving power of vigilance and the importance of early detection.
Cardiologist Dr Robert Routier and cardiothoracic intensive care unit manager Sr Nondumiso Fakude
April 1, 2025
Cardiologist Dr Robert Routier urges the public to check their personal risk factors regularly to help prevent or manage cardiovascular disease.
Obstetrician and gynaecologist Dr Natalie Odell
March 26, 2025
The physical strain pregnancy puts on an expectant mother’s body should not be underestimated. An obstetrician gynaecologist offers her insights for alleviating discomfort and promoting wellbeing with exercise and stretching throughout pregnancy.
Dr Patience Sigwadi
March 19, 2025
Dr Patience Sigwadi, a leading paediatric nephrologist practising at Netcare Unitas Hospital in Centurion, has issued an urgent call for increased focus on skills development to address the escalating kidney disease crisis among children in South Africa.
Paediatric Nephrologist Prof Rajendra Bhimma
March 11, 2025
Paediatric Nephrologist Professor Bhimma was recently awarded the Fellowship to acknowledge his extensive work in research, community-based outreach and teaching of paediatric nephrology, among others.
Prof Bhekifa Dube
March 7, 2025
Netcare congratulates Professor Bhekifa Dube on his invitation to join the European Society for Vascular Surgery's clinical practice guidelines committee. His selection as the only specialist from the continent highlights the significance of this achievement on the global stage.
Rare Disease Day on 28 February 2025
February 28, 2025
The lives of millions of South Africans with a litany of rare diseases can be vastly improved, and even saved, by addressing challenges in identifying, studying and treating their conditions. With Rare Disease Day on the 28th of February 2025, the Rare Diseases Access Initiative (RDAI) is driving an evolution of the country’s healthcare, through innovative strategies to better care for over 4.2million people living with an estimated 7000 rare diseases. “As our healthcare system faces significant changes in the years ahead, it is vital that we also advocate for people living with rare diseases in South Africa, especially those with limited healthcare access,” said Kelly du Plessis, CEO of Rare Diseases South Africa (RDSA), a member of RDAI. “As part of our ongoing research and awareness efforts, RDAI has conducted an initial analysis of the incidence and prevalence of rare diseases within the country.” This research will assist in improving access to healthcare, policy development, and patient advocacy, while giving critical insight into the challenges faced by patients. “According to research, some rare diseases affect fewer than 1 in a million people, while others, such as Down syndrome, cystic fibrosis, and haemophilia, have a more recognisable prevalence,” says Dr. Helen Malherbe, RDAI lead researcher on rare disease prevalence data. “Many conditions are undetected, underdiagnosed or misdiagnosed, with too many having no information available about them at all.” The RDAI was formed in 2019 to promote a more favourable environment for those impacted by rare diseases in South Africa. Participants include Ampath, the Board of Healthcare Funders (BHF), Discovery Health, Genetic Counsellors South Africa (SASHG), the Government Employees Medical Scheme (GEMS), Health Funders Association (HFA), Medihelp, Medscheme, North-West University (NWU), Rare Diseases South Africa (RDSA), the South African Medical Association (SAMA) and The South African Medical Technology Industry Association (SAMED). The Council for Medical Schemes (CMS) participates as an observer. In the same year, Rare Disease International signed a memorandum of understanding with the World Health Organisation leading to an international rare disease policy framework. In 2021, the United Nations General Assembly moved to adopt a resolution recognising 300 million people living with rare diseases worldwide. “A general lack of awareness and delayed diagnosis remain major hurdles for those affected by rare diseases. Policymakers and healthcare stakeholders need to prioritise access to treatment, diagnosis, and support for rare disease patients,” says Bada Pharasi, CEO of IPASA, “Through this initiative, working collaboratively with stakeholders at every level of the healthcare supply chain, we can bring real and meaningful change to those affected, including family members and care givers, through smart and efficient strategies.” The globally agreed definition of a rare disease is any medical condition with a specific pattern of clinical signs, symptoms, and findings that affects fewer than or equal to 1 in 2000 persons in a population. “Most are genetic, and some are inherited and passed down in families,” Malherbe says. “Some affect only the patient’s genetic recipe, while others may be acquired during life due to infection, trauma, or environmental effects. For many, the cause is still unknown. “These conditions mainly affect children, as they are largely incurable and many are life-threatening. Some require specialised and co-ordinated care, some have limited and expensive treatment options, while others have no information or effective treatments at all,” she adds. The RDAI is calling for a patient-centred care model built on equitable access, transparency and efficiency. Naturally, this model calls for the open participation of patients, the healthcare industry, health professionals, and the Government. “The most critical elements are robust diagnosis standards, improved access to treatment, data collection and management, co-ordination of care, measurement of outcomes and ongoing collaborative research,” du Plessis says. “We need to establish rare disease advisory committees, map gaps and opportunities, establish system requirements, create a roadmap and plan a phased implementation with clear timelines.” The RDAI states that these policy development steps would be a start in quantifying the disease burden and defining standards of care. This would be followed by building and strengthening the capacity to facilitate appropriate diagnosis, treatment, continuity and data monitoring. Thoneshan Naidoo, Chief Executive Officer of the Health Funders Association noted that, “We appreciate the unique opportunity provided by RDAI which enables stakeholders across the industry to work together and identify strategies that improve equitable access to the appropriate diagnosis, treatment and healthcare services for rare disease patients, in an affordable and sustainable manner, taking account of the other pressing needs across the healthcare system.” “True innovation in healthcare is only possible through partnerships and joint advocacy efforts that raise awareness and improve access to treatment. Our long-term goal is the development of a rare diseases policy framework and guidelines for coordinated care,” says Pharasi. “Our members are united in the commitment to unlocking improved patient outcomes and improving access to services and robust health needs assessment facilities.” he concludes. About RDAI The Rare Diseases Access Initiative (RDAI) is dedicated to advocating for improved healthcare access, policy development, and patient support for those affected by rare diseases in South Africa. The initiative brings together key healthcare stakeholders, including pharmaceutical associations, funders, genetic specialists, and patient advocacy groups, to drive impactful change. About RDSA Founded in 2013, Rare Diseases South Africa (RDSA) is a non-profit organisation advocating to ensure that people living with rare diseases and congenital disorders experience greater recognition, support, improved health service and better overall quality of life. Started out of personal need following the diagnosis of organisation founder, Kelly du Plessis' son, it became evident that there was a lack of awareness and support for rare diseases in general in South Africa. About IPASA The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association representing 24 leading pharmaceutical companies committed to research, development, and innovation. Our mission is to drive healthcare advancement by advocating for policies that improve patient access to safe, high-quality, and affordable medicines.
Gastroenterologist Dr Barbara Makumbi explains the toll acid reflux can take on your health
February 26, 2025
Gastroenterologist Dr. Barbara Makumbi discusses common risk factors and offers tips for managing reflux and the longer-term condition known as gastroesophageal reflux disease (GORD).
More Posts